For children and adults with sickle cell anemia, pharmaceutical-grade L-glutamine oral therapy alleviates acute pain crises and decreases hospitalizations, according to a recent study.
Researchers at the University of California, San Francisco Benioff Children’s Hospital Oakland, sickle cell organizations, and Emmaus Life Sciences conducted a randomized, double-blind, placebo-controlled, phase 3 trial that compared L-glutamine with placebo among 230 patients (age, 5-58 years) over 48